122 related articles for article (PubMed ID: 2574893)
21. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
Gonier T; Schiele BC; Vestre ND
Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
[No Abstract] [Full Text] [Related]
22. Efficacy of risperidone on positive features of schizophrenia.
McEvoy JP
J Clin Psychiatry; 1994 May; 55 Suppl():18-21. PubMed ID: 7520904
[TBL] [Abstract][Full Text] [Related]
23. A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia.
Georgotas A; Gerbino L; Jordan B; McCarthy M; Gershon S; Kleinberg D; Lautin A; Stanley M; Rotrosen J
Psychopharmacology (Berl); 1981; 73(3):292-4. PubMed ID: 6113618
[TBL] [Abstract][Full Text] [Related]
24. [A randomized double-blinded controlled study on treatment of schizophrenia by in vitro fostered bezoar combined with haloperidol].
Weng SH; Wang GH; Wang XP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1213-5. PubMed ID: 21275180
[No Abstract] [Full Text] [Related]
25. [Treatment of acute schizophrenia with sulforidazine].
Sánchez E; Ning JL; Núñez H; Medina E
Rev Neuropsiquiatr; 1975 Jun; 38(2):94-105. PubMed ID: 1839
[No Abstract] [Full Text] [Related]
26. A comparison of the clinical effects of timiperone, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
Kariya T; Shimazono Y; Itoh H; Mori A; Murasaki M; Sugano K; Toru M; Yamashita I
J Int Med Res; 1983; 11(2):66-77. PubMed ID: 6133803
[TBL] [Abstract][Full Text] [Related]
27. The effects of selected antipsychotic drugs of human judgment.
Gillis JS
Curr Ther Res Clin Exp; 1977 Feb; 21(2):224-32. PubMed ID: 403057
[No Abstract] [Full Text] [Related]
28. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
[No Abstract] [Full Text] [Related]
29. Piperacetazine vs. thioridazine for the control of schizophrenia in outpatients.
Rada RT; Donlon PT
Psychosomatics; 1972; 13(6):373-6. PubMed ID: 4153002
[No Abstract] [Full Text] [Related]
30. Clinical predictors of schizophrenic patient response to neuroleptics.
Korínková V
Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
[No Abstract] [Full Text] [Related]
31. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects.
Väisänen K; Rimón R; Räisänen P; Viukari M
Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446
[TBL] [Abstract][Full Text] [Related]
32. Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease.
Tune LE; Steele C; Cooper T
Psychiatr Clin North Am; 1991 Jun; 14(2):353-73. PubMed ID: 1676507
[TBL] [Abstract][Full Text] [Related]
33. Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
Lingl FA
Psychosomatics; 1973; 14(4):235-40. PubMed ID: 4604344
[No Abstract] [Full Text] [Related]
34. Zetidoline, a new antipsychotic. First controlled trial in acute schizophrenia.
Silverstone T; Levine S; Freeman HL; Dubini A
Br J Psychiatry; 1984 Sep; 145():294-9. PubMed ID: 6148118
[TBL] [Abstract][Full Text] [Related]
35. Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
Manchanda R; Hirsch SR
Br J Psychiatry; 1986 Jun; 148():701-7. PubMed ID: 2877702
[TBL] [Abstract][Full Text] [Related]
36. Sertindole versus haloperidol for schizophrenia.
Balon R
Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
[No Abstract] [Full Text] [Related]
37. Schizophrenia: do we really need placebo-controlled studies?
Storosum JG; Elferink AJ; van Zwieten BJ
Eur Neuropsychopharmacol; 1998 Dec; 8(4):279-86. PubMed ID: 9928917
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of first-episode schizophrenia.
Rosenheck RA
Lancet; 2008 Mar; 371(9618):1048-9. PubMed ID: 18374824
[No Abstract] [Full Text] [Related]
39. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
Rapaport MH; McAllister CG; Kirch DG; Pickar D
Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382
[No Abstract] [Full Text] [Related]
40. Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
Mikkelsen EJ
Schizophr Bull; 1982; 8(2):320-32. PubMed ID: 6126001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
